RYIA
GILD icon

Roehl & Yi Investment Advisors’s Gilead Sciences GILD Stock Holding History

Roehl & Yi Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Buy
2,611
+9
+0.3% +$1.19K 0.11% 147
2026
Q1 		$363K Buy
2,602
+858
+49% +$120K 0.14% 114
2025
Q4 		$214K Buy
+1,744
New +$212K 0.09% 151

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Roehl & Yi Investment Advisors's GILD Position: Q2 2026 in Review

Roehl & Yi Investment Advisors increased its Gilead Sciences (GILD) stake by 0.35% in Q2 2026, buying an estimated $1.19K and bringing the position to 2,611 shares worth $330K. The position accounts for 0.11% of the portfolio, ranked #147.

Roehl & Yi Investment Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $363K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Roehl & Yi Investment Advisors held 2,611 shares of Gilead Sciences worth $330K as of Q2 2026.
  • Roehl & Yi Investment Advisors bought 9 Gilead Sciences shares in Q2 2026, an estimated $1.19K.
  • Gilead Sciences made up 0.11% of Roehl & Yi Investment Advisors's portfolio in Q2 2026, its #147 holding.
  • Roehl & Yi Investment Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Roehl & Yi Investment Advisors's Gilead Sciences position peaked at $363K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Roehl & Yi Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.